Mallinckrodt PLC (NYSE:MNK) – Equities research analysts at Jefferies Financial Group reduced their FY2019 earnings per share (EPS) estimates for Mallinckrodt in a research note issued to investors on Thursday, July 11th. Jefferies Financial Group analyst A. Petrone now anticipates that the company will earn $8.25 per share for the year, down from their previous forecast of $8.35. Jefferies Financial Group currently has a “Reduce” rating and a $10.00 target price on the stock. Jefferies Financial Group also issued estimates for Mallinckrodt’s Q4 2019 earnings at $2.13 EPS, FY2020 earnings at $8.50 EPS, FY2021 earnings at $8.60 EPS and FY2023 earnings at $9.07 EPS.
Mallinckrodt (NYSE:MNK) last announced its earnings results on Tuesday, May 7th. The company reported $1.94 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.73 by $0.21. The business had revenue of $791.00 million during the quarter, compared to analysts’ expectations of $766.27 million. Mallinckrodt had a negative net margin of 118.53% and a positive return on equity of 14.22%. The firm’s revenue for the quarter was up 4.7% on a year-over-year basis. During the same quarter last year, the company posted $1.31 EPS.
MNK opened at $8.59 on Friday. The company has a quick ratio of 1.08, a current ratio of 1.45 and a debt-to-equity ratio of 1.90. The firm has a market cap of $693.14 million, a PE ratio of 1.07, a PEG ratio of 0.08 and a beta of 2.32. Mallinckrodt has a 1-year low of $8.00 and a 1-year high of $36.65. The company has a 50-day moving average of $9.06.
Institutional investors have recently added to or reduced their stakes in the stock. CWM LLC boosted its stake in Mallinckrodt by 222.8% during the 1st quarter. CWM LLC now owns 1,159 shares of the company’s stock worth $25,000 after acquiring an additional 800 shares during the last quarter. QS Investors LLC lifted its stake in Mallinckrodt by 14.3% in the fourth quarter. QS Investors LLC now owns 4,000 shares of the company’s stock valued at $64,000 after buying an additional 500 shares in the last quarter. Anderson Fisher LLC lifted its stake in Mallinckrodt by 1,129.1% in the first quarter. Anderson Fisher LLC now owns 5,285 shares of the company’s stock valued at $115,000 after buying an additional 4,855 shares in the last quarter. Northwestern Mutual Wealth Management Co. lifted its stake in Mallinckrodt by 724.8% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 5,617 shares of the company’s stock valued at $122,000 after buying an additional 4,936 shares in the last quarter. Finally, Xact Kapitalforvaltning AB bought a new position in Mallinckrodt in the second quarter valued at approximately $185,000.
In other Mallinckrodt news, CFO Bryan M. Reasons bought 5,400 shares of Mallinckrodt stock in a transaction dated Friday, June 7th. The shares were bought at an average price of $8.96 per share, with a total value of $48,384.00. Following the purchase, the chief financial officer now owns 17,979 shares of the company’s stock, valued at $161,091.84. The transaction was disclosed in a document filed with the SEC, which is available at this link. Insiders bought a total of 8,400 shares of company stock worth $83,234 in the last ninety days. Insiders own 2.70% of the company’s stock.
Mallinckrodt Company Profile
Mallinckrodt plc, together with its subsidiaries, develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. It operates in two segments, Specialty Brands, and Specialty Generics and Amitiza.
Recommended Story: What is the NASDAQ Stock Market?
Receive News & Ratings for Mallinckrodt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mallinckrodt and related companies with MarketBeat.com's FREE daily email newsletter.